Physician

Ramy Lewez Hanna, M.D.

According to 2025 Medicare claims, Ramy Hanna, M.D. (NPI: 1073732418) practices cardiac electrophysiology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is PUBLIC HOSPITAL DIST NO 1 SKAGIT (NPI: 1023332749; TIN: 562392010) and primary practice location at 98274-4126. Hanna is affiliated with the Cascadia Care Network LLC (ACO ID: A3731) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Hanna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 774 traditional Medicare patients, billed 3,480 HCPCS/CPT codes, and received $217,604 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,848 prescription claims across 772 beneficiaries totaling $966,245 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 16 records totaling $3,451. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $57,264 to $966,245. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	603	2,095	$180,155
2016	634	2,136	$187,262
2017	645	2,472	$214,539
2018	658	2,592	$191,160
2019	711	2,650	$238,301
2020	755	2,848	$204,332
2021	839	3,453	$234,899
2022	857	3,487	$252,690
2023	853	3,587	$235,577
2024	774	3,480	$217,604

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	1,040	$57,264
2016	187	745	$50,345
2017	231	1,066	$108,974
2018	292	1,290	$185,138
2019	346	1,665	$298,078
2020	450	2,073	$384,458
2021	593	2,717	$609,138
2022	633	2,930	$771,861
2023	730	3,678	$1,010,156
2024	772	3,848	$966,245

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	310	$67
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	366	640	$19
93288	Evaluation of single, dual, multiple lead or leadless pacemaker system	231	305	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	229	250	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	192	229	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	446	29,381	$565,862
Xarelto	Rivaroxaban	205	14,440	$260,769
Jardiance	Empagliflozin	13	990	$18,790
Dofetilide	Dofetilide	64	4,950	$18,102
Flecainide Acetate	Flecainide Acetate	342	27,714	$15,397

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$3,451	Siemens Medical Solutions USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramy Lewez Hanna, M.D.?

Tedicare shows public-source Medicare data for Ramy Lewez Hanna, M.D. (NPI 1073732418), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramy Lewez Hanna, M.D. have ACO affiliation data?

Ramy Lewez Hanna, M.D. is shown with ACO affiliation data for Cascadia Care Network LLC (MSSP, ACO ID A3731) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Ramy Lewez Hanna, M.D.?

Ramy Lewez Hanna, M.D. is linked to PUBLIC HOSPITAL DIST NO 1 SKAGIT (billing NPI 1023332749) in the available physician profile data.

Does Ramy Lewez Hanna, M.D. have Open Payments data?

Ramy Lewez Hanna, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.